Improved Survival with Chemotherapy Alone in Limited-stage Hodgkin Lymphoma
January 15, 2012, Volume 3, Issue 2

An important study suggests that radiotherapy may not be a necessary addition to chemotherapy in previously untreated patients with limited-stage Hodgkin lymphoma, sparing patients the risks of late radiati...

Favorable Early-stage Hodgkin Lymphoma and HD.6: The Take-Home and Don’t–Take-Home Messages
January 15, 2012, Volume 3, Issue 2

3.2.07_yahalom.jpg The Canadian HD.6 randomized study in patients with nonbulky early-stage Hodgkin lymphoma is mo...

NIH Panel Endorses Active Surveillance in Low-risk Prostate Cancer
January 15, 2012, Volume 3, Issue 2

Active surveillance of localized prostate cancer is a viable management option that should be offered to low-risk patients in place of immediate treatment, said a panel of experts convened by the National Institutes of Health.

A fairly new concept, active surv...

Estrogen for Vulvovaginal Atrophy in Breast Cancer: Debate Continues
January 15, 2012, Volume 3, Issue 2

3.2.30_simon.jpg Vulvovaginal atrophy is a concern for the majority of patients with breast cancer, not only because of its physical and psychosexual consequenc...

What You Should Know about Denosumab (Prolia) for Increasing Bone Mass during Breast and Prostate Cancer Therapies
January 15, 2012, Volume 3, Issue 2

In the Clinic provides overviews of novel oncology agents, addressing indications, mechanisms, administration recommendations, safety profiles, and other essential information needed for the appropr...

Advances in Gynecologic Cancer Surgery Continue to Improve Outcomes
January 15, 2012, Volume 3, Issue 2

3.2.50_gardner.jpg

Over the past several decades, advances in chemotherapy and surgery have begun to translate into improved survival in gynecologic m...

Therapy for Hodgkin Lymphoma in the Elderly Remains Undefined
January 15, 2012, Volume 3, Issue 2

At the 2011 Pan-Pacific Lymphoma Conference held recently in Kauai, Hawaii, Andrew M. Evens, DO, MSc, Director of the Lymphoma Program at the University of Massachusetts Medical School in Worcester, ...

Studies Reveal that Hormonal Factors Influence Lung Cancer Risk in Women
January 15, 2012, Volume 3, Issue 2

3.2.74_baik.jpg

In an effort to understand lung cancer risk factors and develop prevention strategies f...

RT @JediPD: K-RAS mutation leads to IL-1a and NFk-B "stuck" action into pancreatic cancer: http://t.co/NXrvb4HR http://t.co/NXrvb4HR
about 12 hours ago via web

#Axitinib (#Inlyta) Approved in Advanced Renal Cell Carcinoma (via @FDA) http://t.co/YNmZ3uHG #KidneyCancer
about 12 hours ago via web

RT @KaelanAtPhRMA: Dang...NIH funding/grants sinks to all time low. http://t.co/fasN20TX
about 14 hours ago via web

More thanks 2 more great tweeps! @mtmdphd @orguezfdez @IsabelleTanneau @DrNordquist @hoppy212ny @IvyEyesEditing @drsteventucker #FF
about 16 hours ago via web

Thanks Tweeps! @Berkowitzm @aftimosp @MSKCC_library @oncology23 @jdflaysakier @Lilian610 @DrLauraPorter @CECSarahG @CERNfoundation #FF
about 16 hours ago via web

Improved Survival with Chemotherapy Alone in Limited-stage Hodgkin LymphomaJanuary 15, 2012, Volume 3, Issue 2

Favorable Early-stage Hodgkin Lymphoma and HD.6: The Take-Home and Don’t–Take-Home MessagesJanuary 15, 2012, Volume 3, Issue 2

NIH Panel Endorses Active Surveillance in Low-risk Prostate CancerJanuary 15, 2012, Volume 3, Issue 2

Estrogen for Vulvovaginal Atrophy in Breast Cancer: Debate ContinuesJanuary 15, 2012, Volume 3, Issue 2

What You Should Know about Denosumab (Prolia) for Increasing Bone Mass during Breast and Prostate Cancer TherapiesJanuary 15, 2012, Volume 3, Issue 2

Advances in Gynecologic Cancer Surgery Continue to Improve OutcomesJanuary 15, 2012, Volume 3, Issue 2

Therapy for Hodgkin Lymphoma in the Elderly Remains UndefinedJanuary 15, 2012, Volume 3, Issue 2

Studies Reveal that Hormonal Factors Influence Lung Cancer Risk in WomenJanuary 15, 2012, Volume 3, Issue 2